Abstract
IntroductionSARS-CoV-2 (COVID-19) has caused an international pandemic of respiratory illness, resulting in significant healthcare and economic turmoil. To date, no robust vaccine or treatment has been identified. Elemental zinc has previously been demonstrated to have beneficial effects on coronaviruses and other viral respiratory infections due to its effect on RNA polymerase. Additionally, zinc has well-demonstrated protective effects against hypoxic injury—a clear mechanism of end-organ injury in respiratory distress syndrome. We aimed to assess the effect of high-dose intravenous zinc (HDIVZn) on SARS-CoV-2 infection. The end of study analyses will evaluate the reduction of impact of oxygen saturations or requirement of oxygen supplementation.Methods and analysisWe designed a double-blind randomised controlled trial of daily HDIVZn (0.5 mg/kg) versus placebo. Primary outcome measures are lowest oxygen saturation (or greatest level of supplemental oxygenation) for non-ventilated patients and worst PaO2/FiO2 for ventilated patients. Following power calculations, 60 hospitalised patients and 100 ventilated patients will be recruited to demonstrate a 20% difference. The duration of follow-up is up to the point of discharge.Ethics and disseminationEthical approval was obtained through the independent Human Research Ethics Committee. Participant recruitment will commence in May 2020. Results will be published in peer-reviewed medical journals.Trial registration numberACTRN126200000454976.
Reference49 articles.
1. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis
2. Tu H , Tu S , Gao S , et al . The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event. J Infect 2020.
3. COVID-19: knowns, unknowns, and questions;Weston;mSphere,2020
4. Zhu J , Zhong Z , Li H , et al . Ct imaging features of 4,121 patients with COVID-19: a meta-analysis. J Med Virol 2020.
5. How does COVID-19 kill? uncertainty is hampering doctors' ability to choose treatments;Ledford;Nature,2020
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献